WaferGen Revenues Drop 55 Percent in Q2 as Loss Narrows | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems saw its second-quarter revenues fall 55 percent year over year, while its net loss narrowed sharply, it disclosed after the close of the market on Friday.

In its Form 10-Q filed with the US Securities and Exchange Commission, the Fremont, Calif.-based firm said that revenues for the quarter totaled $20,158, down from $44,905 a year ago, primarily due to lower sales of the Real-Time PCR Chip panels and of the SmartSlide consumables.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.